Skip to main content
SpringerLink
Log in

Results of adjuvant therapy in resected pancreatic cancer

  • Original Articles
  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

After an apparently curative resection, most patients develop local recurrence within the resection bed. In addition, almost all develop liver metastases. This implies that the surgical resection, even if extended, seldom is enough, and that an adjuvant treatment must be effective not only against systemic spread, but also against local recurrence. However, the time schedule may be different for different types of recurrence, resulting in different time frames for the adjuvant treatment. Although extended radical operations may increase the proportion of patients who can undergo resections, the incidence of local recurrences seems unchanged. There are, however, no randomized studies yet comparing the “Standard Whipple” with more extended resection. Intraoperative radiation (IORT) has failed to demonstrate a difference in long-term survival, but there have been reports of a decreased frequency of local progression at the site of the primary tumor. Therefore, it is encouraging that IORT seems to diminish the local recurrences after radical resections. However, randomized studies are also missing for this procedure. There are today only three published studies of adjuvant chemotherapy after radical pancreaticoduodenectomy, but a few more will be finished shortly. Still, the results have not convincingly shown that modern chemotherapy with or without radiotherapy prolongs the life of the patients, and there is little evidence for improving the quality of life. However, since the results are far from satisfactory after resection, more efforts should be made to find better treatment modalities, including adjuvant protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kelsen DP. Adjuvant therapy of upper gastrointestinal tract cancer.Semin Oncol 1995; 22: 582–599.

    PubMed  CAS  Google Scholar 

  2. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas.Int J Radiat Oncol Biol Phys 1991; 21: 1137–1143.

    PubMed  CAS  Google Scholar 

  3. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma.Cancer 1990; 66: 56–61.

    Article  PubMed  CAS  Google Scholar 

  4. Westerdahl J, Andrén-Sandberg Å, Ihse I. Recurrence of exocrine pancreatic cancer—local or hepatic?Hepatogastroenterol 1993; 40: 384–387.

    CAS  Google Scholar 

  5. Andrén-Sandberg Å, Ihse I. Pattern of recurrence after pancreaticoduodenectomy for exocrine pancreatic cancer—correlation to survival, inPancreaticoduodenectomy, Hanyo H., ed. Springer-Verlag, Tokyo, 1996; in press.

    Google Scholar 

  6. Abrams RA, Grochow LB. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.Surg Clin North Am 1995; 75: 925–938.

    PubMed  CAS  Google Scholar 

  7. Amikura K, Kobari M, Matsuno S. The time of occurrence of liver metastasis in carcinoma of the pancreas.Int J Pancreatol 1995; 17: 139–146.

    PubMed  CAS  Google Scholar 

  8. Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area.Cancer 1978; 41: 880–887.

    Article  PubMed  CAS  Google Scholar 

  9. Nagakawa T, Kobayashi H, Uneo K, Ohta T, Kayahara M, Miyazaki I. Clinical study of lymphatic flow to the para-aortic lymph nodes in carcinoma of the head of the pancreas.Cancer 1994; 73: 1155–1162.

    Article  PubMed  CAS  Google Scholar 

  10. Hosch SB, Rehders A, Pantel K, Broelsch CE, Izbicki JR. Incidence and prognostic significance of minimal tumor cell dissemination in lymph nodes of patients with pancreatic cancer. Pancreas Club Inc, Program 30th Annual Meeting May 19, 1996, San Francisco, p. 30.

  11. Tsunoda T, Ura K, Eto T, Matsumoto T, Tsuchiya R. UICC and Japanese stage classifications for carcinoma of the pancreas.Int J Pancreatol 1991; 8: 205–214.

    PubMed  CAS  Google Scholar 

  12. Zerbi A, Balzano G, Bottura R, Di Carlo V. Reliability of pancreatic cancer staging classifications.Int J Pancreatol 1994; 15: 13–18.

    PubMed  CAS  Google Scholar 

  13. Lillemoe KD, Yeo CJ, Pitt HA, Hruban RH, Sohn TA, Nakeeb A, Sauter PK, Cameron JL. Pancreaticoduo-denectomy—does it have a role in the palliation of pancreatic carcinoma? Pancreas Club Inc. Program 30th Annual Meeting May 19, 1996, San Francisco, p. 32.

  14. Manabe T, Ohshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas.Cancer 1989; 64: 1132–1137.

    Article  PubMed  CAS  Google Scholar 

  15. Nagakawa T, Kayahara M, Ueno K, Ohta T, Konishi I, Ueda N, Miyazaki I. A clinicopathologic study of neural invasion in cancer of the pancreatic head.Cancer 1992; 69: 930–935.

    Article  PubMed  CAS  Google Scholar 

  16. Kayahara M, Nabakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging.Cancer 1993; 72: 2118–2123.

    Article  PubMed  CAS  Google Scholar 

  17. del Castillo CF, Warshaw L. Peritoneal metastases in pancreatic carcinoma.Hepato-Gastroenterology 1993; 40: 430–432.

    PubMed  Google Scholar 

  18. Ihse I, Andersson H, Andrén-Sandberg Å. Total pancreatectomy for cancer of the pancreas: is it appropriate?World J Surg 1996; 20: 288–294.

    Article  PubMed  CAS  Google Scholar 

  19. Ihse I, Axelson J, Al-Sharaf K, Andrén-Sandberg Å. Surgery of periampullary cancer.Dig Surg 1994; 11: 402–407.

    Article  Google Scholar 

  20. Ihse I, Andersson R, Axelson J, Kobari M, Andrén-Sandberg Å. Does tumor size influence early and late results after resection of pancreatic adenocarcinoma?J Hep Bil Panc Surg 1995; 2: 371–375.

    Article  Google Scholar 

  21. Isgar B, Neoptolemos J. Adjuvant therapy after resection of pancreatic cancer, inPancreatic Disease Progress and Prospects, Johnson CD, Imrie CW, eds. Springer-Verlag, London, 1991; pp. 103–113.

    Google Scholar 

  22. Treurniet-Donker AD, Van Mierlo MJM, Van Putten WW. Localized unresectable pancreatic cancer.Int J Radiat Oncol Biol Phys 1990; 18: 59–62.

    PubMed  CAS  Google Scholar 

  23. Smith IE, Courtenay VD, Mills J, Peckham MJ. In vitro radiation response of cells from four human tumours propagated in immune-suppressed mice.Cancer Res 1978; 38: 390–395.

    PubMed  CAS  Google Scholar 

  24. Bosset JF, Pavy JJ, Gillet M, Mantion G, Pelisser E, Schraub S. Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: result of a prospective study.Radiother Oncol 1992; 24: 191–194.

    Article  PubMed  CAS  Google Scholar 

  25. Douglass HO. Adjuvant therapy for pancreatic cancer.World J Surg 1995; 19: 270–274.

    Article  PubMed  Google Scholar 

  26. Roldan GE, Gunderson LL, Nagomey DM, Martin JK, Ilstrup DM, Holbrook MA, Kvols LK, McIlrath DC. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer.Cancer 1988; 61: 1110–1116.

    Article  PubMed  CAS  Google Scholar 

  27. Tepper JE, Noyes D, Krall JM, Sause WT, Wolkov HB, Dobelbower RR, Thomson J, Owens J, Hanks GE. Intra-operative radiation therapy of pancreatic carcinoma: a report of RTOG-8505.Int J Radiat Oncol Biol Phys 1991; 21: 1145–1149.

    PubMed  CAS  Google Scholar 

  28. Dobelbower RR, Konski AA, Merrick HW. Intraoperative electron beam radiation therapy (IOEBRT) and post-operative precision external beam radiation therapy (PEBRT) for adenocarcinoma of the pancreas. A report of 60 cases, inIntraoperative Radiation Therapy. Proceeding 4th International Symposium, Schildberg FW, Willich N, Krämling HJ, eds. Verlag die blaue Eule, Essen 1993; pp. 301–308.

    Google Scholar 

  29. Rich TA, Evans DB, Levin B. Current status of IORT in the treatment of pancreatic cancer, inIntraoperative Radiation Therapy. Proceeding 4th International Symposium, Schildberg FW, Willich N, Krämling HJ, eds. Verlag die blaue Eule, Essen, 1993; pp. 273–277.

    Google Scholar 

  30. Abe M, Shibamoto Y, Nishimura Y. Intraoperative radiotherapy for pancreatic cancer in Japan: multi-institutional and Kyoto University experience, inIntraoperative Radiation Therapy. Proceeding 4th International Symposium, Schildberg FW, Willich N, Krämling HJ, eds. Verlag die blaue Eule, Essen, 1993; 278–281.

    Google Scholar 

  31. Gotoh M, Monden M, Sakon M, Kanai T, Umeshita K, Ikeda H, Mori T. Control of subclinical disease by intraoperative radiotherapy after radical resection of pancreatic cancer, inIntraoperative Radiation Therapy. Proceeding 4th International Symposium, Schildberg FW, Willich, N, Krämling HJ, eds. Verlag die blaue Eule, Essen, 1993; 294–296.

    Google Scholar 

  32. Madhu JJ, Flam MS, Legha SS.Chemoradiation, an Integrated Approach to Cancer Treatment. Lea & Febiger, Philadelphia, 1993.

    Google Scholar 

  33. Holyoke ED, Mittelman A, Panahon A for the Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma.N Engl J Med 1985; 312: 1465–1472.

    Article  Google Scholar 

  34. Moertel CG, Childs DS, Reitemeier RJ, Colby MY, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.Lancet 1969; 626: 865–867.

    Article  Google Scholar 

  35. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitmeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO, Thomas F, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation+5-fluorouracil.Cancer 1981; 48: 1705–1710.

    Article  PubMed  CAS  Google Scholar 

  36. March JC, Livestone EM, Knowlton AH for the Gastrointestinal Tumor Study Group. Radiation therapy combined with Adrimycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma.Cancer 1985; 56: 2563–2568.

    Article  Google Scholar 

  37. Klaassen DJ, Macintyre JM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil—an Eastern Cooperative Oncology Group study.J Clin Oncol 1985; 3: 373–378.

    PubMed  CAS  Google Scholar 

  38. Douglass HO, Arbuck S, Nava H for the Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone.J Natl Cancer Inst 1988; 80: 751–755.

    Article  Google Scholar 

  39. Kahn PJ, Skornick Y, Inbar M, Kaplan O, Chaichik S, Rozin R. Surgical palliation combined with synchronous therapy in pancreatic carcinoma.Eur J Surg Oncol 1990; 16: 7–11.

    PubMed  CAS  Google Scholar 

  40. Tepper JE, Shipley WU, Warshaw AL, Nardi GL, Wood WC, Orlow EL. The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.J Clin Oncol 1987; 5: 579–584.

    PubMed  CAS  Google Scholar 

  41. Kalser MH, Ellenberg SS for the Gastrointestinal Tumor Study Group. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.Arch Surg 1985; 120: 899–903.

    PubMed  CAS  Google Scholar 

  42. Douglass HO, Kalser MH, Stablein DM, Steinberg SM for the Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer.Cancer 1987; 59: 2006–2010.

    Article  Google Scholar 

  43. Douglass HO, Stablein DM. Ten-year follow-up of first generation surgical adjuvant studies of the Gastrointestinal Tumor Study Group, inAdjuvant Therapy of Cancer IV, Salmon SE, ed. Saunders, Philadelphia, 1990; pp. 405–415.

    Google Scholar 

  44. Neoptolemos JP, Kerr DJ. Adjuvant therapy for pancreatic cancer.Br J Surg 1995; 82: 1012–1014.

    Article  PubMed  CAS  Google Scholar 

  45. Splinter TA, Obertop H, Kok TC, Jeekel J. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A nonrandomised pilot study.J Cancer Res Clin Oncol 1989; 115: 200–202.

    Article  PubMed  CAS  Google Scholar 

  46. Bakkevold KE, Amesjö B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater—results of a controlled, prospective, randomised multicentre study.Eur J Cancer 1993; 29A: 698–703.

    Article  PubMed  CAS  Google Scholar 

  47. Ishikawa O, Ohigashi H, Sasaki Y, Furukawa H, Kabuto T, Kameyama M, Nakamori S, Hiratsuka M, Imaoka S. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastases after extended pancreatectomy for adenocarcinoma of the pancreas.Am J Surg 1994; 168: 361–364.

    Article  PubMed  CAS  Google Scholar 

  48. Bramhall SR, Neoptolemos JP. Adjuvant therapy.Curr Pract Surg 1994; 6: 161–166.

    Google Scholar 

  49. Sindelar WF, Kinsell TJ. Randomized trial of intraoperative radiotherapy in resected carcinoma of the pancreas.Int J Radiat Oncol Biol Phys 1986; 12(Suppl 1): 148.

    Google Scholar 

  50. Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudscher C, Di Carlo V. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer.Cancer 1994; 73: 2930–2935.

    Article  PubMed  CAS  Google Scholar 

  51. Garton GR, Gunderson LL, Nagorney DM, Donohue JH, Martin JK, McIlrath DC, Cha SS. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer.Int J Radiat Oncol Biol Phys 1993; 27: 1153–1157.

    PubMed  CAS  Google Scholar 

  52. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.Ann Surg 1993; 217: 144–148.

    Article  PubMed  CAS  Google Scholar 

  53. Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.Int J Radiat Oncol Biol Phys 1994; 30: 161–167.

    PubMed  CAS  Google Scholar 

  54. Weese JL, Nussbaum ML, Paul AR, Engstrom PF, Solin LJ, Kowalyshyn MJ, Hoffman JF. Increase resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy.Int J Pancreatol 1990; 8: 177–185.

    Article  Google Scholar 

  55. Andrén-Sandberg Å, Bäckman PL. Hormone therapy of pancreatic ductal cancer, inThe Pancreas, A Clinical Textbook, Beger HG, Warshaw AL, Carr-Locke DL, Russell C, Büchler M, Neoptolemos J, Sarr MG, eds. Blackwell Scientific Publications, Oxford, 1996; in press.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Lund University Hospital, S-221 85, Lund, Sweden

    Åke Andrén-Sandberg, Pia Lena Bäckman & Roland Andersson

Authors
  1. Åke Andrén-Sandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pia Lena Bäckman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrén-Sandberg, Å., Bäckman, P.L. & Andersson, R. Results of adjuvant therapy in resected pancreatic cancer. Int J Pancreatol 21, 31–38 (1997). https://doi.org/10.1007/BF02785917

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785917

Key Words

Search

Navigation